In our study ciprofloxacin treatment potently decrease Dnmt1 levels in SSc dermal and lung fibroblasts, while upregulating Fli1 gene expression and downregulating COL1A1 and COL1A2 mRNA. Here, COL1A1 is linked to systemic sclerosis.